Ryan Allway December 14th, 2018 Uncategorized California’s cannabis industry is projected to reach $5.1 billion by the end of 2019, according to BDS Analytics, but unexpected challenges have slowed progress. These challenges range from excessive regulations to sky-high taxation. Investors looking for opportunities in the state may want... Read more
Ryan Allway December 14th, 2018 Uncategorized Cannabis and chocolate have a long history together. While “pot brownies” are perhaps the original cannabis edible, professional chefs and food scientists have refined the process of infusing cannabinoids and chocolates to create unique innovations. Investors may want to take a closer... Read more
Ryan Allway December 14th, 2018 Exclusive, Top News The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s... Read more
Ryan Allway December 14th, 2018 Exclusive, News, Top News The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, following the legalization of adult-use cannabis earlier this year. While early sales have been brisk, the industry faces key challenges with safety... Read more
Ryan Allway December 14th, 2018 Exclusive, News, Top Story The Canadian cannabis market is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. While many companies are focused on supplying the recreational market, the medical market may... Read more
Ryan Allway December 12th, 2018 Exclusive, News, Top Story California’s cannabis industry is the largest in the country with revenue expected to reach $5.1 billion by 2022, according to Arcview Market Research and BDS Analytics. With about 40 million residents and a long history of cannabis usage, the... Read more
Ryan Allway December 6th, 2018 Exclusive, News, Top Story Canada’s cannabis industry has charged forward full-steam following the legalization of recreational cannabis in October. While there was an initial flurry in provincial agreements, many licensed producers experienced a shortfall in their supply commitments. These dynamics encouraged many provinces... Read more
Ryan Allway December 5th, 2018 Partnership formed with Dr. Don Garbuz, an award winning orthopaedic surgeon and medical researcher, credited with over 120 peer reviewed publications. The parties will seek to conduct a clinical study with orthopaedic patients, using Canntab’s sustained release tablets. The study aims to show... Read more
– FSD Pharma to work with Canntab to create tablets for the clinical research study at its facility in Cobourg, Ontario, Canada – FSD Pharma Inc. (“FSD Pharma”) (HUGE.CN) (FSDDF) (0K9.F) today congratulated strategic partner Canntab Therapeutics Limited (“Canntab”) (CSE:PILL) (TBF1.F) on the launch of a research partnership with... Read more
Ryan Allway December 5th, 2018 Exclusive, News, Top News The North American cannabis industry is littered with companies touting global ambitions. There are regular announcements regarding letters of intent to distribute in emerging markets like Europe and Latin America, long on potential and short on concrete details. Many... Read more